WELL$191.07
Chart
Performance
Key Stats
AI WELL Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
BuyWelltower shows strong long-term prospects driven by demographic trends and a solid financial position, but current technicals suggest a cautious approach due to overbought conditions. Investors should consider the attractive dividend yield and stable growth.
Thematic
Welltower is well-positioned to benefit from the aging population and increasing demand for healthcare services and senior housing. Its focus on high-quality, well-located assets provides a competitive advantage.
Fundamental
Welltower exhibits strong financial health with consistent revenue growth and healthy profitability. The dividend yield is attractive, and the balance sheet is robust, though P/E ratios indicate a premium valuation.
Technical
The stock is in an uptrend and trading above key moving averages. However, some indicators suggest it might be approaching overbought territory, indicating potential for consolidation.
| Factor | Score |
|---|---|
| Demographic Trends (Aging Population) | 95 |
| Healthcare Infrastructure Demand | 85 |
| Real Estate Market Focus | 70 |
| Geographic Diversification | 75 |
| Regulatory Environment | 55 |
| Factor | Score |
|---|---|
| Valuation | 45 |
| Profitability | 80 |
| Growth | 85 |
| Balance Sheet Health | 85 |
| Cash Flow | 90 |
| Dividend Yield | 80 |
| Factor | Score |
|---|---|
| Trend Analysis | 70 |
| Momentum | 60 |
| Support & Resistance | 50 |
| Volume | 60 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Strong Recent Performance
The stock price has increased by 1.59% in the last trading session and shows positive performance across multiple short-term periods (5D: 2.24%, 1M: 1.81%).
Positive Valuation Ratios
The Price to Sales (PS) ratio for 2024 is 10.4, and the Price to Earnings (PE) ratio is 85.8, which, while high, could be considered reasonable within the context of the company's growth prospects if it continues to expand.
Bearish Points (7)
High P/E Ratio
The trailing Price-to-Earnings (P/E) ratio is 122.6, which is significantly high and may indicate the stock is overvalued compared to its earnings.
Inconsistent EPS Performance
There have been several instances of significant negative EPS surprises (e.g., Q1 2025: -53.8%, Q1 2024: -43.4%), indicating a degree of unpredictability in earnings delivery.
Calendar
May 2025
14
Ex-Dividend Date
May 2025
22
Next Dividend Date
July 2025
29
Next Earnings Date
H: $0.42
A: $0.42
L: $0.42
H: 2.60B
A: 2.49B
L: 2.38B
Profile
Welltower Inc. (NYSE: WELL), an S&P 500 company, is one of the world's preeminent residential wellness and healthcare infrastructure companies. We seek to position our portfolio of 1,500+ seniors and wellness housing communities at the intersection of housing, healthcare, and hospitality, creating vibrant communities for mature renters and older adults in the United States, United Kingdom, and Canada. We also strive to support physicians in our outpatient medical buildings with the critical infrastructure needed to deliver quality care. We believe our real estate portfolio is unmatched, located in highly attractive micro-markets with stunning built environments. Yet, we are an unusual real estate organization as we view ourselves as a product company in a real estate wrapper, driven by relationships and an unconventional culture. Through our disciplined approach to capital allocation powered by our Data Science platform and superior operating results driven by our operating platform, the Welltower Business System, we aspire to deliver long-term compounding of per share growth and returns for our existing investors our North Star.
Seasonals
Price Target
168.35 USD
The 39 analysts offering 1 year price forecasts for WELL have a max estimate of 240.00 and a min estimate of 145.00.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 95
A major Canadian telecommunications company with a dominant TELUS Health division, which is a direct competitor to WELL Health in digital health, virtual care (Babylon by TELUS Health), EMR (PCC), and pharmacy solutions, making it a comprehensive rival in the Canadian market.
Weight: 90
A direct Canadian competitor to WELL Health, offering an integrated approach to digital health, including virtual care, EMR systems, and allied health services, often cited alongside WELL as a leading Canadian digital health player.
Weight: 88
Parent company of Shoppers Drug Mart, which acquired QHR Technologies (Accuro EMR, a direct competitor to WELL's EMR offerings) and has a significant investment in virtual care (Maple), positioning Loblaw as a major player in Canadian retail health and health tech.
Weight: 85
A global leader in virtual care services, Teladoc is a benchmark and direct competitor in the telehealth space, a core component of WELL Health's offerings and growth strategy.